logo-loader
viewTerra Tech Corp.

Buds & Duds: Cannabis stocks slip, Aurora takes hit on major analyst downgrade

Analysts at Piper Sander tagged the company with a Sell rating and a price target of US$1, down from US$3

Cannabis stock board
Analyst Michael Lavery doesn’t expect Aurora to achieve positive cash flow from operations until the third quarter of fiscal 2021

The cannabis sector had a quiet day  at the end of the week, but most of the major indices trended lower.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, slipped 0.4% to 113.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF ticked down 0.2% to C$8.36, while the OTCQX Cannabis index gained 1.3% to 451.2 points. 

Buds

Among the lucky few to buck the downward pull was Terra Tech Corp (OTCMKTS:TRTC), which climbed 7.6% to US$0.18.

Others on the upswing included 1933 Industries Inc (CSE:TGIF) (OTCMKTS:TGIFF), which gained 2.4% to C$0.21 on the CSE and 2.4% to US$0.16 on OTC Markets, and Aphria Inc (TSE:APHA), which traded 1.9% higher at US4.92.

Duds

The biggest drop of the day belonged to Aurora Cannabis Inc (TSE:ACB) (NYSE:ACB), which took a dive after analysts at Piper Sandler tagged the company with a 'Sell' rating and a price target of US$1, down from US$3, according to reports.

Analyst Michael Lavery doesn’t expect Aurora to achieve positive cash flow from operations until the third quarter of fiscal 2021, and the company will have to refinance C$360 million of debt due in August of that year. 

Shares dropped 9.1% to C$2.20 in Toronto and 9.1% to US$1.69 in New York.

Also lower were Youngevity International Inc (NASDAQ:YGYI), down 7.3% to US$2.91; Cronos Group Inc (TSE:CRON) (NASDAQ:CRON) down 3.4% to C$8.90 in Toronto and 3.3% to US$6.82 in New York; and Emerald Health Therapeutics Inc down 4.6% to US$0.25.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: Terra Tech Corp.

Price: 0.18125 USD

OTCQX:TRTC
Market: OTCQX
Market Cap: $20.84 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Bulls, Bears & Brokers: Alto Capital’s Tony Locantro on Nyrada IPO and small...

Alto Capital investment manager and stock market commentator Tony Locantro updates Proactive on this week's listing of Nyrada Inc (ASX:NYR), a spin-off of Noxopharm Ltd’s (ASX:NOX). He discusses the reasons for the spin-off, including some of the recent and expected trading patterns. Locantro...

1 week, 1 day ago

2 min read